NovoCure (NVCR) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

NovoCure Revenue Highlights

Latest Revenue (Y)

$509.34M

Latest Revenue (Q)

$155.09M

Main Geography (Y)

UNITED STATES

NovoCure Revenue by Period

NovoCure Revenue by Year

Date	Revenue	Change
2023-12-31	$509.34M	-5.30%
2022-12-31	$537.84M	0.53%
2021-12-31	$535.03M	8.23%
2020-12-31	$494.37M	40.72%
2019-12-31	$351.32M	41.62%
2018-12-31	$248.07M	40.13%
2017-12-31	$177.03M	113.57%
2016-12-31	$82.89M	150.52%
2015-12-31	$33.09M	113.60%
2014-12-31	$15.49M	49.53%
2013-12-31	$10.36M	-

NovoCure generated $509.34M in revenue during NA 2023, up -5.30% compared to the previous quarter, and up 205.32% compared to the same period a year ago.

NovoCure Revenue by Quarter

Date	Revenue	Change
2024-09-30	$155.09M	3.15%
2024-06-30	$150.36M	8.56%
2024-03-31	$138.50M	3.53%
2023-12-31	$133.78M	5.08%
2023-09-30	$127.32M	1.01%
2023-06-30	$126.05M	3.17%
2023-03-31	$122.18M	-4.86%
2022-12-31	$128.43M	-1.96%
2022-09-30	$131.00M	-7.01%
2022-06-30	$140.87M	2.41%
2022-03-31	$137.55M	3.25%
2021-12-31	$133.21M	-0.29%
2021-09-30	$133.61M	0.07%
2021-06-30	$133.52M	-0.87%
2021-03-31	$134.69M	-6.43%
2020-12-31	$143.95M	8.51%
2020-09-30	$132.66M	14.44%
2020-06-30	$115.92M	13.84%
2020-03-31	$101.83M	2.61%
2019-12-31	$99.23M	7.79%
2019-09-30	$92.06M	6.17%
2019-06-30	$86.71M	18.28%
2019-03-31	$73.31M	5.22%
2018-12-31	$69.67M	7.59%
2018-09-30	$64.76M	5.27%
2018-06-30	$61.51M	18.01%
2018-03-31	$52.13M	-2.86%
2017-12-31	$53.66M	7.09%
2017-09-30	$50.11M	30.57%
2017-06-30	$38.38M	10.02%
2017-03-31	$34.88M	15.34%
2016-12-31	$30.24M	39.53%
2016-09-30	$21.67M	20.96%
2016-06-30	$17.92M	37.28%
2016-03-31	$13.05M	5.41%
2015-12-31	$12.38M	38.31%
2015-09-30	$8.95M	36.83%
2015-06-30	$6.54M	25.63%
2015-03-31	$5.21M	37.02%
2014-12-31	$3.80M	-13.10%
2014-09-30	$4.37M	-

NovoCure generated $155.09M in revenue during Q3 2024, up 3.15% compared to the previous quarter, and up 123.04% compared to the same period a year ago.

NovoCure Revenue Breakdown

NovoCure Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
International Markets	$136.37M	-	-	-	-
JAPAN	$31.67M	$32.78M	$34.64M	$29.08M	$17.91M
UNITED STATES	$349.74M	$406.89M	$353.11M	$340.78M	$232.81M
CHINA	$23.22M	$21.33M	$22.77M	$12.59M	$5.25M
GERMANY	$60.21M	$46.12M	$93.94M	$93.26M	$86.56M
Other EMEA	-	$30.71M	$30.58M	-	-
EMEA	-	-	-	$18.65M	$8.78M

NovoCure's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (58.17%), International Markets (22.68%), GERMANY (10.01%), JAPAN (5.27%), and CHINA (3.86%).

Quarterly Revenue by Country

Country	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
CHINA	$4.63M	$5.85M	$4.94M	$4.40M	$6.76M	$6.75M	$5.32M	$4.87M	$6.16M	$5.93M	$4.37M	$5.80M	$6.51M	$4.93M	$5.53M	$4.53M	$4.28M	$2.14M	$1.64M	$1.95M
JAPAN	$8.58M	$7.66M	$7.82M	$7.55M	$7.59M	$7.86M	$8.67M	$7.89M	$7.87M	$8.27M	$8.75M	$8.83M	$8.78M	$8.75M	$8.28M	$7.92M	$7.52M	$7.18M	$6.45M	$5.58M
UNITED STATES	$98.34M	$95.71M	$90.54M	$91.31M	$86.24M	$86.96M	$85.23M	$98.62M	$102.65M	$108.20M	$97.42M	$92.03M	$88.03M	$87.14M	$85.91M	$97.68M	$92.64M	$81.21M	$69.26M	$65.87M
FRANCE	$15.24M	$14.27M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
GERMANY	$16.99M	$15.10M	$15.75M	$14.66M	$14.68M	$15.74M	$15.12M	$9.75M	$6.78M	$10.35M	$19.24M	$19.00M	$23.21M	$25.36M	$26.36M	$27.24M	$22.76M	$21.47M	$21.80M	$22.50M
International Markets	$52.13M	$48.80M	$43.02M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Others Countries	-	-	-	-	$12.05M	$8.74M	$7.85M	-	-	-	-	-	-	-	-	-	-	-	-	-
EMEA, Exculding Germany	-	-	-	-	-	-	-	-	$7.54M	$8.11M	$7.78M	$7.08M	$7.33M	$8.62M	$5.47M	$3.93M	$2.67M	-	-	-
EMEA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-60.73M

NovoCure's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (50.20%), International Markets (26.61%), GERMANY (8.67%), FRANCE (7.78%), JAPAN (4.38%), and CHINA (2.36%).

NovoCure Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
MASI	Masimo	$2.05B	$504.60M
PODD	Insulet	$1.70B	$372.60M
ITGR	Integer	$1.60B	$746.27M
GMED	Globus Medical	$1.57B	$625.71M
CNMD	CONMED	$1.24B	$316.70M
LIVN	LivaNova	$1.15B	$318.11M
PEN	Penumbra	$1.06B	$301.04M
INSP	Inspire Medical Systems	$624.80M	$203.19M
NVCR	NovoCure	$509.34M	$155.09M
NARI	Inari Medical	$493.63M	$153.39M
IRTC	iRhythm	$492.68M	$147.54M
INMD	InMode	$492.05M	$80.28M
TMDX	TransMedics Group	$241.62M	$-12.24M

NVCR Revenue FAQ

What is NovoCure’s yearly revenue?

NovoCure's yearly revenue for 2023 was $509.34M, representing a decrease of -5.30% compared to 2022. The company's yearly revenue for 2022 was $537.84M, representing an increase of 0.53% compared to 2021. NVCR's yearly revenue for 2021 was $535.03M, representing an increase of 8.23% compared to 2020.

What is NovoCure’s quarterly revenue?

NovoCure's quarterly revenue for Q3 2024 was $155.1M, a 3.15% increase from the previous quarter (Q2 2024), and a 21.81% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $150.36M, a 8.56% increase from the previous quarter (Q1 2024), and a 19.28% increase year-over-year (Q2 2023). NVCR's quarterly revenue for Q1 2024 was $138.5M, a 3.53% increase from the previous quarter (Q4 2023), and a 13.36% increase year-over-year (Q1 2023).

What is NovoCure’s revenue growth rate?

NovoCure's revenue growth rate for the last 3 years (2021-2023) was -4.80%, and for the last 5 years (2019-2023) was 44.98%.